SkyQuest Technology Group recently introduced MicroRNA Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The MicroRNA Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
MicroRNA Market size was valued at USD 1.35 Billion in 2023 and is poised to grow from USD 1.52 Billion in 2024 to USD 4.04 Billion by 2032, growing at a CAGR of 12.90% during the forecast period (2025-2032).
According to the estimates from the American Cancer Society, 609,360 deaths from cancer were registered in 2022 alone in the US, and over 1.9 million people were newly diagnosed with cancer. In addition, the pace at which microRNA diagnostics gained ground in clinical settings brought forward developments in precision medicine of cancer. As per the microRNA market analysis, the two key factors driving the growth of the market include growing prevalence of such diseases as cancer, heart disease, and other neurological conditions worldwide and rapid developments in genomic technologies.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/microrna-market
Since miRNAs play a crucial role in the post-transcriptional regulation of gene expression, they are rapidly being recognized as robust biomarkers of human disorders. Support for their utility as diagnostic and prognostic biomarkers in the form of blood is seen through their stability within serum and plasma. In addition, circulating miRNAs inside exosomes are serum biomarkers used to elucidate information regarding the immunological status in both healthy and pathological states.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The MicroRNA Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Component
Services [Type (Isolation & Purification, miRNA cDNA Synthesis, Profiling, Localization, & Quantification, Functional Analysis, Others), Specimen (Whole Blood, Serum, Plasma, FFPE, Fresh Frozen Tissue, Others)], Products [Instruments (Technology {Real Time PCR, Microarray, NGS, Others}, Workflow {Isolation & Purification, miRNA cDNA Synthesis, Profiling, Localization, & Quantification, Functional Analysis & Others, Others}), Consumables (Specimen {Workflow, Isolation & Purification, miRNA cDNA Synthesis, Profiling, Localization, & Quantification, Functional Analysis & Others, Others}, Whole Blood {Serum, Plasma, FFPE, Fresh Frozen Tissue, Others})]
Application
Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others
End-use
Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Others
MicroRNA Market – Regional Analysis:
– MicroRNA North America Market includes (Canada, Mexico, USA)
– MicroRNA Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– MicroRNA Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– MicroRNA South America Market includes (Brazil, Argentina)
– MicroRNA Oceania Market (Australia & New Zealand)
Top Market Players in MicroRNA Market are:
Thermo Fisher Scientific, Inc. (US)
QIAGEN (Germany)
NanoString Technologies, Inc. (US)
Merck KGaA (Germany)
Takara Bio, Inc. (Japan)
BioGenex (US)
GeneCopoeia, Inc. (US)
New England Biolabs (US)
Agilent Technologies, Inc. (US)
Illumina, Inc. (US)
Abcam plc (UK)
Roche Holding AG (Switzerland)
Arcturus Therapeutics Ltd. (US)
Synthego Corporation (US)
Bio-Techne Corporation (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Asuragen, Inc. (US)
Cell Signaling Technology, Inc. (US)
Molecular Cloud (China)
Ribomed Biotechnologies, Inc. (US)
Sirnaomics Inc. (US)
FAQ
– What challenges and constraints are affecting the market?
– What geographical variables are influencing the MicroRNA market?
– How does the Value Chain concept offer insights into market dynamics?
– Which country dominates the market?
– Which is the leading formulation type for MicroRNA Market?
Also Read –
https://www.skyquestt.com/report/hydration-backpack-market
https://www.skyquestt.com/report/professional-skincare-market
Forward-Looking Insights
The MicroRNA Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
